当社は、２０１５年１０月にあすか製薬発足１０周年を迎え、２０２０年の創立１００周年に向けて、経営ビジョンである「競争力のあるスペシャリティファーマ」を実現するためのチャレンジを次々と始めております。
近年、社会の医療に対する期待は、多様化する医療ニーズとともに益々高まっております。当社は、強みである内科、産婦人科、泌尿器科の重点３領域に経営資源を集中させ、新薬を柱に医薬品の開発を積極的に進め、社会に貢献してまいります。
また、社会との公正な関係性を構築するため、コーポレートガバナンスおよびコンプライアンスを重視し、適切な情報公開を行い、より一層の倫理性と透明性を確保するための活動を展開してまいります。
今後も、人々の「生命（いのち）」に関わる企業として社会的責任を遂行し、ステークホルダーの皆さまから信頼いただけるよう、また、社員が誇りを持てる企業であるよう弛まぬ努力を続けてまいります。
皆さま方には、より一層のご指導、ご鞭撻を賜りますようお願い申し上げます。 Since its foundation, ASKA has developed business activities with the aim of becoming a trusted pharmaceutical company based on the business philosophy, “Contribute toward the improvement of people’s health and progress in the medicine through the development of innovative products”.ASKA celebrated its 95th anniversary in June 2015. Toward its centenary in 2020, we will be a specialty pharma having a strong presence in the medical industry through creating unique pharmaceutical products.
Recently, the expectation for some medical services has been increasingly rising because of the wider range of medical needs. We mainly focus on three fields: Internal medicine, the obstetrics and gynecology department, and the urology department. We will apply the skills and experience over the company’s history with the development of innovative products for people’s health and quality of life in our specific fields.
Furthermore, ASKA promotes to “Construction of the Corporate Governance System” and “Thoroughness of Compliance”. We will promptly disclose to stakeholder to fulfill corporate social responsibility through indicating ethicality and transparency of management.
We aim to develop high-value medicines for the medical needs. ASKA will continue its unceasing efforts to become a corporation that obtains the trust from all stakeholders.
We will greatly appreciate your further guidance and encouragement.